Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
86 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113752 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113770 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114430 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114433 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-06-18 | 2020-08-21 | 118259 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-21 | 2020-09-03 | 99429 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-11-21 | 2020-04-23 | 99435 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-28 | 2020-08-21 | 99959 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88189 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88192 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88195 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-04-23 | 88198 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88201 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88204 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2020-05-01 | 2020-08-21 | 113791 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2020-05-08 | 2020-08-21 | 114439 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137899 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137902 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |